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Abstract 
Apolipoprotein A-I (apoA-I) is the main protein constituent of high density 
lipoprotein (HDL - the “good cholesterol”). Oxidatively damaged apoA-I has been 
isolated from circulating plasma and atherosclerosis plaque with the amino acid 
residue tryptophan 72 (W72) of apoA-I  identified as a primary oxidation 
site.  ApoA-I designed to include specific oxidized amino acids can be used to 
further investigate the role of site-specific oxidative damage in 
atherosclerosis.  Genetic encoding of oxidized amino acids through orthogonal 
tRNA/aminoacyl-tRNA synthetase (aaRS) pairs offers a reliable method for 
producing site-specific oxidized proteins. Our project involves the generation of 
Saccharomyces tryptophan-RS mutants for recognition of oxidized tryptophan 
(ox-W) but not naturally occurring tryptophan. To study the role of oxidative 
damage on HDL function we need oxidized proteins that mimic the oxidatively 
damaged protein observed in vivo. Thus, our goal was to produce site-specific 
oxidized apoA-I (ox-W72) for incorporation into reconstituted nascent HDL. The 
two aims we hope to achieve within this project are 1) to provide targeted 
mutations that increase the specificity and affinity of aaRS towards 2-hydroxy-
W-apoA-I, as well as  2) express and confirm the presence of ox-W72 in modified 
apoA-I. 
 
  
